July 22, 2019
Bayer recalls two lots of Kogenate
Bayer is voluntarily recalling two lots of Kogenate FS antihemophilic factor (recombinant) 2000 IU vials in the United States to the patient level, the company said Monday in a statement.
Pharmaceuticals, Biotechnology and Life Sciences
Bayer is voluntarily recalling two lots of Kogenate FS antihemophilic factor (recombinant) 2000 IU vials in the United States to the patient level, the company said Monday in a statement.
Rebinyn got US FDA’s approval and is hoped to become an important tool for physicians to help patients manage their bleeds.